The Centers for Disease Control and Prevention (CDC) has announced a new grant opportunity under the number RFA-DP-24-081, titled “Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations in Community Health Settings.” This discretionary funding opportunity aims to explore the feasibility, effectiveness, and cost-effectiveness of innovative public health interventions for improving glaucoma detection and management in high-risk populations within community health care settings. With an estimated total funding of $15,000,000 and an award ceiling of $950,000, this initiative is set to make a significant impact in the realm of chronic disease prevention and control.
The grant has two main components: Component A focuses on comparative effectiveness trials of community-based interventions in diverse locations, targeting populations at high risk due to factors like lack of access to resources and vision specialists. The goal is to establish a standard investigative protocol through collaborative efforts. Component B involves establishing a coordinating center to handle data storage, harmonize data collection and analysis, and provide logistic and communication support to enhance the productivity of Component A’s activities. This initiative is particularly crucial given that glaucoma is a leading cause of irreversible blindness in the United States, with a significant portion of the affected population unaware of their condition. The CDC’s effort through this grant aims to build on previous successes in large-scale glaucoma studies among high-risk groups, emphasizing cost-effective strategies, the inclusion of allied health professionals, community mobilization, technological advancements, and the potential for real-world clinical practice adoption. This comprehensive approach is expected to significantly influence population health, public policy, and implementation strategies in the field of eye health and chronic disease management.
Opportunity ID: 348858
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DP-24-081 |
| Funding Opportunity Title: | Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations in Community Health Settings |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | |
| Expected Number of Awards: | 5 |
| CFDA Number(s): | 93.068 — Chronic Diseases: Research, Control, and Prevention |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Nov 28, 2023 |
| Last Updated Date: | Nov 28, 2023 |
| Original Closing Date for Applications: | Feb 05, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
| Current Closing Date for Applications: | Feb 05, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
| Archive Date: | Mar 06, 2024 |
| Estimated Total Program Funding: | $ 15,000,000 |
| Award Ceiling: | $950,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Special district governments Independent school districts Native American tribal governments (Federally recognized) Small businesses State governments County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities For profit organizations other than small businesses City or township governments |
| Additional Information on Eligibility: | This is a new, competitive NOFO. Prior agreements, funding, collaborations, and other arrangements with CDC are not evidence of eligibility for this NOFO. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The purpose of this notice of funding opportunity (NOFO) is to investigate the feasibility, effectiveness, and cost-effectiveness of high-quality and innovative public health interventions to improve glaucoma detection and management among high-risk populations within community-based health care delivery settings. This NOFO has two components:Component A: Comparative effectiveness trials of community-based interventions in high-risk populations in diverse locations. Communities include populations living with undiagnosed eye diseases due to lack of access, resources, vision specialists, etc. Award recipients are expected to collaborate to establish a standard investigative protocol.Component B: A coordinating center to provide data storage (if needed), harmonize data collection and data analysis, logistic and communication support to enhance the efficiency, productivity for component A.Glaucoma is one of the leading causes of irreversible blindness in the United States, and the leading cause of blindness among African Americans. Of an estimated 2.7 million people with glaucoma, 50% of them are unaware of their condition. Given the low prevalence in the general population, this NOFO focuses on people at high-risk for glaucoma and does not include broad general screening programs.In the past decade, large-scale glaucoma studies funded by CDC among high-risk groups have demonstrated success in screening and follow-up care to slow disease progression through innovative delivery programs. CDC intends to further this research by funding projects with strategies that are cost-effective, comprehensive, and include allied health care professionals (e.g. community healthcare workers, ophthalmic technicians, navigators); mobilize community partners and resources; use advanced technological approaches; demonstrate potential for adoption into real-world clinical practice; and have the greatest potential to affect population health, public policy, and implementation. |
| Link to Additional Information: | https://sightstudies.org |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact: Alison Amoroso
uxl8@cdc.gov |